When is Medicare available for rTMS?
As of 1 November 2021, new items for Repetitive Transcranial Magnetic Stimulation (rTMS) therapy services have been added to the Medicare Benefits Schedule (MBS) for eligible patients with diagnosed medication-resistant major depressive disorder. The four new items will make MBS subsidised rTMS therapy available for patients over the age of 18 years who have tried at least two classes of antidepressants and remain unwell. It will cover patients who have not received rTMS therapy previously. Medicare will cover 85% of the treatment costs. Further details can be found though the link below: